Polyclonal immunoglobulins for intravenous use do not influence the behaviour of cultured oligodendrocytes

Journal of Neuroimmunology

Volumn 96, Issue 2, 1999, Pages 228-233

  Stangel, Martin ^a,b   Compston, Alastair ^a,b   Scolding, Neil J ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Intravenous immunoglobulins (IVIg); Oligodendrocyte precursors; Remyelination

Indexed keywords

IMMUNOGLOBULIN; POLYCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENCEPHALOMYELITIS; IMMUNOPHARMACOLOGY; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; REMYELINIZATION;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; IMMUNOGLOBULINS, INTRAVENOUS; OLIGODENDROGLIA; RATS; STEM CELLS;

EID: 0033519265     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00035-1     Document Type: Article

References (22)

1. Achiron A., Gabbay U., Gilad R., Hassin-Baer S., Barak Y., Gornish M., Elizur A., Goldhammer Y., Sarova-Pinhas I. Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses. Neurology. 50:1998;398-402.
2. Asakura K., Miller D.J., Murray K., Bansal R., Pfeiffer S.E., Rodriguez M. Monoclonal autoantibody SCH94.03, which promotes CNS remyelination, recognizes an antigen on the surface of oligodendrocytes. J. Neurosci. Res. 43:1996;273-281.
3. Asakura K., Miller D.J., Pease L.R., Rodriguez M. Targeting of IgMk antibodies to oligodendrocytes promotes CNS remyelination. J. Neurosci. 18:1998;7700-7708.
4. Bansal R., Gard A.L., Pfeiffer S.E. Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid. J. Neurosci. Res. 21:1988;260-267.
5. Carroll W.M., Jennings A.R., Ironside L.J. Identification of the adult resting progenitor cell by autoradiographic tracking of oligodendrocyte precursors in experimental CNS demyelination. Brain. 121:1998;293-302.
6. Cohen J.A., Williams W.V., Geller H.M., Greene M.I. Anti-reovirus receptor antibody accelerates expression of the optic nerve oligodendrocyte developmental program. Proc. Natl. Acad. Sci. USA. 88:1991;1266-1270.
7. Austrian Immunoglobulin in Multiple Sclerosis Study Group, Fazekas F., Deisenhammer F., Strasser-Fuchs S., Nahler G., Mamoli B. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Lancet. 349:1997;589-593.
8. Fok-Seang J., Mathews G.A., ffrench-Constant C., Trotter J., Fawcett J.W. Migration of oligodendrocyte precursors on astrocytes and meningeal cells. Dev. Biol. 171:1995;1-15.
9. Gabriel C.M., Gregson N.A., Redford E.J., Davies M., Smith K.J., Hughes R.A.C. Human immunoglobulin ameliorates rat experimental autoimmune neuritis. Brain. 120:1997;1533-1540.
10. Keirstead H.S., Blakemore W.F. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J. Neuropathol. Exp. Neurol. 56:1997;1191-1201.
11. Kekow J., Reinhold D., Pap T., Ansorge S. Intravenous immunoglobulins and transforming growth factor β Lancet. 351:1998;184-185.
12. McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85:1980;890-902.
13. McKinnon R.D., Piras G., Ida J.A., Dubois-Dalq M. A role for TGF-β in oligodendrocyte differentiation. J. Cell Biol. 121:1993;1397-1407.
14. Milner R., Edwards G., Streuli C., ffrench-Constant C. A role in migration for the αvβ1 integrin expressed on oligodendrocyte precursors. J. Neurosci. 16:1996;7240-7252.
15. Pashov A., Dubey C., Kaveri S.V., Lectard B., Huang Y., Kazatchkine M.D., Bellon B. Normal immunoglobulin G protects against experimental allergic encephalomyelitis by inducing transferable T cell unresponsiveness to myelin basic protein. Eur. J. Immunol. 28:1998;1823-1831.
16. Pavelko K.D., van Engelen B.G.M., Rodriguez M. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination. J. Neurosci. 18:1998;2498-2505.
17. Rodriguez M., Lennon V.A. Immunoglobulins promote remyelination in the central nervous system. Ann. Neurol. 27:1990;12-17.
18. Rodriguez M., Lindsley M.D. Immunosuppression promotes CNS remyelination in chronic virus-induced demyelinating disease. Neurology. 42:1992;348-357.
19. Rodriguez M., Miller D.J., Lennon V.A. Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology. 46:1996;538-545.
20. Scolding N.J., Frith S., Linington C., Morgan B.P., Campbell A.K., Compston D.A.S. Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation. J. Neuroimmunol. 22:1989;169-176.
21. Sekul E.A., Culper E.J., Dalakas M.C. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann. Intern. Med. 121:1994;259-262.
22. Sorensen P.S., Wanscher B., Jensen C.V., Schreiber K., Blinkenberg M., Ravnborg M., Kirsmeier H., Larsen V.A., Lee M.L. Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis. Neurology. 50:1998;1273-1281.